XML 69 R59.htm IDEA: XBRL DOCUMENT v3.26.1
Loss Per Share - Schedule of Loss Per Share (Details) - AUD ($)
6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Loss Per Share [Abstract]    
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (12,552,490) $ (10,453,811)
Weighted average number of ordinary shares used in calculating basic loss per share 1,560,213,259 425,157,427
Weighted average number of ordinary shares used in calculating diluted loss per share 1,560,213,259 425,157,427
Basic loss per share $ (0.805) $ (2.459)
Diluted loss per share $ (0.805) $ (2.459)